tiprankstipranks
Roche CEO says no plans for job cuts, business healthy, Reuters reports
PremiumThe FlyRoche CEO says no plans for job cuts, business healthy, Reuters reports
22d ago
RBC sees justification for Prothena rebound after study miss
Premium
The Fly
RBC sees justification for Prothena rebound after study miss
1M ago
Prothena price target lowered to $22 from $26 at BofA
Premium
The Fly
Prothena price target lowered to $22 from $26 at BofA
1M ago
Roche Vabysmo PFS approved in EU for three retinal conditions
PremiumThe FlyRoche Vabysmo PFS approved in EU for three retinal conditions
1M ago
Genentech presents updated fixed-duration Columvi and Lunsumio data at ASH
Premium
The Fly
Genentech presents updated fixed-duration Columvi and Lunsumio data at ASH
1M ago
Roche commences tender offer for outstanding Poseida shares at $9 per share
Premium
The Fly
Roche commences tender offer for outstanding Poseida shares at $9 per share
1M ago
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
PremiumThe FlyTrump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
2M ago
Poseida Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
Poseida Therapeutics downgraded to Neutral from Buy at BTIG
2M ago
Roche reports SKYSCRAPER-01 study misses primary endpoint
Premium
The Fly
Roche reports SKYSCRAPER-01 study misses primary endpoint
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100